Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Gurunanthan Palani"'
Publikováno v:
Endocrine Practice. 29:286-294
To review the clinical presentation, causes and diagnostic approach to spontaneous hypoglycemia in adults without diabetes mellitus.Literature review was performed using PubMed and Google Scholar databases.Hypoglycemia is uncommon in people who are n
Publikováno v:
Diabetes Technol Ther
BACKGROUND: Cystic fibrosis-related diabetes (CFRD) is associated with pulmonary decline, compromised nutritional status, and earlier mortality. Although diabetes technology is increasingly being used in individuals with CFRD, there is a paucity of d
Publikováno v:
Cureus.
Publikováno v:
Journal of the Endocrine Society. 5:A148-A149
Introduction: Classic pheochromocytoma symptoms include headache, diaphoresis, palpitations and symptomatic pheochromocytomas are on average around 5cm. They respond to preoperative alpha blockade followed by surgery. We present a case of a giant 15.
Publikováno v:
Journal of the Endocrine Society
Untreated or inadequately treated overt hyperthyroidism in pregnancy can have devastating consequences for both mother and fetus. At the same time antithyroid drugs (ATDs) are known for their teratogenic effect and should be avoid when possible; once
Autor:
Gurunanthan Palani
Publikováno v:
Endocrine Practice. 26:250-251
Publikováno v:
World Journal of Cardiovascular Diseases. :222-227
Purpose: Regadenoson (REG) is currently becoming the stress agent of choice in patients undergoing pharmacologic single photon emission computed tomography (SPECT). However, in patients with left bundle branch block (LBBB) and ventricular paced rhyth
Publikováno v:
Cardiology in Review. 21:42-48
Myocardial perfusion imaging is a well-established noninvasive modality for the diagnosis and prognosis of coronary artery disease. The pharmacologic stress agents adenosine and dipyridamole are widely used in imaging studies, but cause undesirable s
Publikováno v:
Coronary Artery Disease-Assessment, Surgery, Prevention
Coronary artery disease is a leading cause of morbidity and mortality in developed countries. According to a Center for Disease Control report, one out of four deaths is attributed to coronary artery disease. It costs the United States human lives, p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::892593b52b13445ec084af59793c04b5
https://doi.org/10.5772/61154
https://doi.org/10.5772/61154
Autor:
Vanji Karthikeyan, Karthik Ananthasubramaniam, Gurunanthan Palani, Rafael Cabrera Salinas, Zehra Husain, Aarthee S. Karthikeyan
Publikováno v:
Journal of Nuclear Cardiology. 18:605-611
Pharmacokinetic studies suggest delayed clearance of Regadenoson (REG), a new selective A2A receptor agonist in chronic kidney disease (CKD). The safety of REG in large series of CKD patients in daily clinical practice remains unstudied.Retrospective